(19)
(11) EP 1 715 878 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.08.2009 Bulletin 2009/32

(45) Mention of the grant of the patent:
11.03.2009 Bulletin 2009/11

(21) Application number: 04806442.2

(22) Date of filing: 27.12.2004
(51) International Patent Classification (IPC): 
A61K 36/488(2006.01)
A61P 3/10(2006.01)
 A61K 31/70(2006.01)
(86) International application number:
PCT/IB2004/004273
(87) International publication number:
WO 2005/074958 (18.08.2005 Gazette 2005/33)

(54)

USE OF THE LUPINOSIDE PA4 OR A BUTANOL FRACTION OF AN EXTRACT OF PUERARIA TUBEROSA FOR THE TREATMENT OF DIABETES TYPE 2

VERWENDUNG DES LUPINOSIDS PA4 ODER EINER BUTANOL-FRAKTION EINES PUERARIA TUBEROSA-EXTRAKTS ZUR BEHANDLUNG VON TYP-2 DIABETES

UTILISATION DU LUPINOSIDE PA4 OU D'UN FRACTION BUTANOLIQUE D'UN EXTRAIT DE PUERARIA TUBEROSA POUR LE TRAITEMENT DU DIABÈTE DU TYPE 2

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 09.01.2004 US 535332 P

(43) Date of publication of application:
02.11.2006 Bulletin 2006/44

(73) Proprietor: Council of Scientific and Industrial Research
New Delhi 110 001 (IN)

(72) Inventors:
  • BHATTACHARYA, Samir
    Kolkata 700 032 (IN)
  • DEY, Debleena, Indian Instit. of Chemical Biol.
    Kolkata 700 032 (IN)
  • MANDAL, Swapan Kumar
    Kolkata 700 032 (IN)
  • MUKHERJEE, Mohua, Indian Inst. of Chemical Biol.
    Kolkata 700 032 (IN)
  • PAL, Bikash Chandra
    Kolkata 700 032 (IN)
  • BISWAS, Tanushree
    Kolkata 700 032 (IN)
  • DATTA, Malabika
    Kolkata 700 032 (IN)
  • ROY, Sib Sankar
    Kolkata 700 032 (IN)
  • BANDYOPADHYAY, Arun
    Kolkata 700 032 (IN)
  • BANDOPADHYAY, Santu
    Kolkata 700 032 (IN)
  • KONAR, Aditya
    Kolkata 700 032 (IN)
  • GIRI, Bir Bhanu
    Purulia, West Bengal 700 032 (IN)

(74) Representative: Behnisch, Werner 
Reinhard, Skuhra, Weise & Partner GbR Patent- und Rechtsanwälte Friedrichstrasse 31
80801 München
80801 München (DE)


(56) References cited: : 
WO-A-03/017784
 US-A1- 2003 185 913
   
  • NAHAR PHARMACEUTICALS: "DIABEEN" INTERNET ARTICLE, [Online] 13 December 2003 (2003-12-13), XP002329344 Retrieved from the Internet: URL:http://naharpharma.com/patent_formulat ions.htm> [retrieved on 2005-05-17]
  • NADAN HERBAL PHARMACY: "Pueraria tuberosa" INTERNET ARTICLE, [Online] 17 February 2003 (2003-02-17), XP002329345 Retrieved from the Internet: URL:http://www.nadanherbcomp.com.au/herb-p .html> [retrieved on 2005-05-18]
  • SHUKLA, S. ET AL.: "Butanolic Extract of Pueraria tuberosa DC.: Physiological Response in the Genital Tract of Cyclic Female Rats" PHYTOTHERAPY RESEARCH, vol. 3, no. 1, 1989, pages 5-10, XP008047503
  • KINJO, J. ET AL.: "Study of Structure-Hepatoprotective Relationships of Oleanene-Type Triterpenoidal Glucuronides Obtained from Several Fabaceous Plants on Rat Primary Hepatocyte Cultures" BIOLOGICAL AND PHARMACEUTICAL BULLETIN, vol. 22, no. 2, February 1999 (1999-02), pages 203-206, XP008047269
  • KINJO, J. ET AL.: "Five New Triterpene Glycosides from Russell Lupine" CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 42, no. 9, September 1994 (1994-09), pages 1874-1878, XP008047299 cited in the application
  • GUPTA, D.N. ET AL.: "Postcoital contraceptive efficacy and hormonal profile of Pueraria tuberosa" INDIAN DRUGS, vol. 27, no. 7, 1990, pages 372-374, XP008051624
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).